China approves two more domestic Covid-19 vaccines, increasing number to 4 | World News - Hindustan Times
close_game
close_game

China approves two more domestic Covid-19 vaccines, increasing number to 4

Reuters |
Feb 25, 2021 08:47 PM IST

The two newly approved vaccines are made by CanSino Biologics Inc and Wuhan Institute of Biological Products, an affiliate of China National Pharmaceutical Group (Sinopharm).

China's National Medical Products Administration said on Thursday that it had approved two more Covid-19 vaccines for public use, increasing the number of domestic vaccines approved in China to four.

FILE - In this Sept. 24, 2020, file photo, a worker inspects syringes of a vaccine for COVID-19 produced by Sinovac at its factory in Beijing. China approved two new more COVID-19 vaccines for wider use Thursday, adding to its growing arsenal of shots: one from CanSino Biologics, and a second one from state-owned Sinopharm. (AP Photo/Ng Han Guan, File)(AP)
FILE - In this Sept. 24, 2020, file photo, a worker inspects syringes of a vaccine for COVID-19 produced by Sinovac at its factory in Beijing. China approved two new more COVID-19 vaccines for wider use Thursday, adding to its growing arsenal of shots: one from CanSino Biologics, and a second one from state-owned Sinopharm. (AP Photo/Ng Han Guan, File)(AP)

The two newly approved vaccines are made by CanSino Biologics Inc and Wuhan Institute of Biological Products, an affiliate of China National Pharmaceutical Group (Sinopharm).

Hindustan Times - your fastest source for breaking news! Read now.

They join a vaccine from Sinovac Biotech approved earlier this month, and another from Sinopharm's Beijing unit approved last year.

So far, China has not approved Covid-19 vaccines developed by Western drug makers.

Sinopharm's Wuhan unit said on Wednesday its vaccine had an efficacy rate of 72.51% against the Covid-19 disease caused by the virus, citing interim analysis of late-stage clinical trial data, without offering more details.

It is one of two candidates from Sinopharm that have entered Phase III clinical trials overseas, and was earlier given to a limited group of people at higher infection risk.

The four approved Chinese vaccines can be stored at normal freezer temperatures, making them a potentially attractive option for developing countries which might have difficulty deploying vaccines from Pfizer and Moderna that require much colder temperatures for longer-term storage.

China has been exporting the Sinovac and earlier Sinopharm vaccines to countries around the world.


Unlock a world of Benefits with HT! From insightful newsletters to real-time news alerts and a personalized news feed – it's all here, just a click away! - Login Now! Get Latest World News along with Latest News from India at Hindustan Times.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Tuesday, February 27, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On